Viewing Study NCT05360758


Ignite Creation Date: 2025-12-25 @ 12:12 AM
Ignite Modification Date: 2025-12-25 @ 10:13 PM
Study NCT ID: NCT05360758
Status: UNKNOWN
Last Update Posted: 2022-12-28
First Post: 2022-04-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Ibrutinib Adapted to Response in Patients With CLL
Sponsor: Grupo Argentino de Tratamiento de la Leucemia Aguda
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module